S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
ASX:HPR

High Peak Royalties (HPR) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free HPR Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
5.95%
Price Target
N/A
Stock Analysis
Stock Analysis
HPR stock logo

About High Peak Royalties Stock (ASX:HPR)

High Peak Royalties Limited, together with its subsidiaries, engages in the acquisition of royalty and exploration interests in oil and gas assets in the United States. It also holds 100% interest in four geothermal energy licenses covering 2,767 square kilometers located in South Australia. The company was incorporated in 2006 and is based in Sydney, Australia.

HPR Stock News Headlines

April 19, 2024 | americanbankingnews.com
David Croll Buys 699,822 Shares of High Peak Royalties Limited (ASX:HPR) Stock
April 18, 2024 | msn.com
High Peak house prices increased slightly in February
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
April 16, 2024 | americanbankingnews.com
High Peak Royalties Limited (ASX:HPR) Insider David Croll Buys 280,000 Shares of Stock
April 10, 2024 | msn.com
Onshore wind and Solar power farms in High Peak could fuel tens of thousands of homes
April 8, 2024 | msn.com
Food hygiene ratings handed to 13 High Peak establishments
April 4, 2024 | msn.com
Road closures: five for High Peak drivers over the next fortnight
March 29, 2024 | msn.com
Number of people accessing pandemic debt relief help in High Peak rose last year
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
March 20, 2024 | msn.com
High Peak house prices increased slightly in January
March 20, 2024 | msn.com
Nearly a quarter of High Peak homes deemed ‘non-decent’
March 18, 2024 | msn.com
Road closures: four for High Peak drivers over the next fortnight
March 11, 2024 | msn.com
Several High Peak heritage sites considered at risk
March 9, 2024 | finance.yahoo.com
High Peak Royalties Limited's (ASX:HPR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
March 2, 2024 | msn.com
Multiple rough sleepers in High Peak – as numbers across England soar
February 9, 2024 | msn.com
Number of new social housing lets in High Peak fell by a fifth over last decade
January 15, 2024 | msn.com
Road closures: one for High Peak drivers over the next fortnight
January 12, 2024 | msn.com
One in six people in High Peak work in high emission industries
January 11, 2024 | msn.com
A fifth of adults in High Peak suffer joint, bone and muscle issues
January 8, 2024 | msn.com
Good news as food hygiene ratings handed to three High Peak establishments
January 4, 2024 | msn.com
FTSE 100 CEOs match High Peak residents' annual pay by 12pm on Thursday January 4
December 28, 2023 | msn.com
High Peak road closures: one for motorists to avoid over the next fortnight
December 21, 2023 | msn.com
Where are the busiest train stations in High Peak?
December 20, 2023 | msn.com
Cost of Christmas dinner rises nearly twice as fast as High Peak wages
December 20, 2023 | msn.com
High Peak house prices increased slightly in October
December 19, 2023 | msn.com
Good news as food hygiene ratings awarded to three High Peak establishments
December 8, 2023 | msn.com
Almost 100 water pollution incidents in High Peak since 2018
See More Headlines
Receive HPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for High Peak Royalties and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/16/2018
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Energy
Industry
Oil & Gas E&P
Sub-Industry
N/A
Current Symbol
ASX:HPR
CUSIP
N/A
CIK
N/A
Web
www.highpeak.com.au
Phone
+61-2-82960011
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
21.63%
Pretax Margin
N/A
Return on Equity
3.46%
Return on Assets
2.82%

Debt

Debt-to-Equity Ratio
11.82
Current Ratio
1.15
Quick Ratio
2.55

Sales & Book Value

Annual Sales
$1.47 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
12.78
Book Value
A$0.05 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
208,060,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
0.05
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

HPR Stock Analysis - Frequently Asked Questions

How were High Peak Royalties' earnings last quarter?

High Peak Royalties Limited (ASX:HPR) issued its earnings results on Friday, March, 16th. The company reported $0.00 EPS for the quarter. High Peak Royalties had a net margin of 21.63% and a trailing twelve-month return on equity of 3.46%.

What other stocks do shareholders of High Peak Royalties own?

Based on aggregate information from My MarketBeat watchlists, some companies that other High Peak Royalties investors own include Novavax (NVAX), Co-Diagnostics (CODX), Livongo Health (LVGO), BlueLinx (BXC), Caledonia Mining (CMCL), Civeo (CVEO), Maxar Technologies (MAXR), BowFlex (NLS), Sorrento Therapeutics (SRNE) and Barrick Gold (ABX).

This page (ASX:HPR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media